Huningue, France

Stefan Hildbrand

This inventor holds 1 USPTO granted patent. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Hildbrand. Retrieved from https://idiyas.com/inventor/stefan-hildbrand-z2ttlvof

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Hildbrand

Introduction

Stefan Hildbrand is a notable inventor based in Huningue, France. He has made significant contributions to the field of chemistry, particularly in the development of new compounds. His work has led to the creation of innovative solutions that have potential applications in various industries.

Latest Patents

Stefan Hildbrand holds a patent for a process titled "PROCESS FOR PREPARING SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES." This patent showcases his expertise in synthesizing complex chemical structures, which can be crucial for pharmaceutical development. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Hildbrand is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. His role involves research and development, where he applies his innovative thinking to create new products and improve existing ones. His contributions have been instrumental in driving the company's success in the competitive pharmaceutical market.

Collaborations

Stefan has collaborated with Joséphine Eliette Françoise Cinqualbre, working together to explore new avenues in their research. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in scientific research.

Conclusion

Stefan Hildbrand's work exemplifies the spirit of innovation in the field of chemistry. His patent and contributions to F. Hoffmann-La Roche AG highlight his dedication to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…